Rival treatments had mixed results in the past AstraZeneca sees $3-5 billion peak annual sales for its drug Detailed results to be presented at upcoming medical conference Shares among biggest gainers ...
In the 2000s, when the AIDS pandemic hit South Africa, we were seeing a lot of children dying from HIV. That was just before ...
University of Colorado Denver Biomedical Engineering Associate Professor Chelsea Magin is developing a lung model to help ...
NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...
Nanyang Technological University, Singapore (NTU Singapore) is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB ...
Onlymyhealth on MSN
Understanding Dyspnoea: Expert Guide On Its Causes, Symptoms, And Treatment
Shortness of breath can be triggered by different factors such as anxiety, stress, or intense workouts. The medical term for ...
Dr Christine Bestvina discusses EGFR treatment shifts, KRAS trial data, and expanding clinical trial access for community oncologists. Lung cancer treatment has undergone a remarkable transformation ...
Nationally, there has been a rise in the number of children and adolescents with congenital and acquired heart disease ...
A hormone traditionally used to treat bone loss may hold the key to stopping chronic back pain at its source, according to a new study. Chronic back pain is often linked to the deterioration of spinal ...
Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...
The Pulmonary Rehab Program at Topeka's Stormont Vail helps people with chronic lung conditions reach goals for active living ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results